NCT01979484View on ClinicalTrials.gov

Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Pharmacokinetic Assessments in Healthy Volunteers
Interventions
DRUG

PPI-668 capsule

DRUG

PPI-668 tablet

Trial Locations (1)

14202

Buffalo Clinical Research Center, Buffalo

Sponsors
All Listed Sponsors
lead

Presidio Pharmaceuticals, Inc.

INDUSTRY

NCT01979484 - Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations | Biotech Hunter | Biotech Hunter